BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 20363629)

  • 1. Discovery and structural optimization of pyrazole derivatives as novel inhibitors of Cdc25B.
    Chen HJ; Liu Y; Wang LN; Shen Q; Li J; Nan FJ
    Bioorg Med Chem Lett; 2010 May; 20(9):2876-9. PubMed ID: 20363629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thieno[3,2-c]pyrazoles: a novel class of Aurora inhibitors with favorable antitumor activity.
    Bindi S; Fancelli D; Alli C; Berta D; Bertrand JA; Cameron AD; Cappella P; Carpinelli P; Cervi G; Croci V; D'Anello M; Forte B; Giorgini ML; Marsiglio A; Moll J; Pesenti E; Pittalà V; Pulici M; Riccardi-Sirtori F; Roletto F; Soncini C; Storici P; Varasi M; Volpi D; Zugnoni P; Vianello P
    Bioorg Med Chem; 2010 Oct; 18(19):7113-20. PubMed ID: 20817473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of novel thiazolopyrimidines as CDC25B phosphatase inhibitors.
    Kolb S; Mondésert O; Goddard ML; Jullien D; Villoutreix BO; Ducommun B; Garbay C; Braud E
    ChemMedChem; 2009 Apr; 4(4):633-48. PubMed ID: 19212959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of new inhibitors of Cdc25B dual specificity phosphatases by structure-based virtual screening.
    Lavecchia A; Di Giovanni C; Pesapane A; Montuori N; Ragno P; Martucci NM; Masullo M; De Vendittis E; Novellino E
    J Med Chem; 2012 May; 55(9):4142-58. PubMed ID: 22524450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and biological evaluation of a new family of potent inhibitors of the dual specificity protein phosphatase Cdc25.
    Lazo JS; Aslan DC; Southwick EC; Cooley KA; Ducruet AP; Joo B; Vogt A; Wipf P
    J Med Chem; 2001 Nov; 44(24):4042-9. PubMed ID: 11708908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of novel thiadiazole amides as potent Cdc25B and PTP1B inhibitors.
    Li Y; Yu Y; Jin K; Gao L; Luo T; Sheng L; Shao X; Li J
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4125-8. PubMed ID: 25124112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cdc25B dual-specificity phosphatase inhibitors identified in a high-throughput screen of the NIH compound library.
    Johnston PA; Foster CA; Tierno MB; Shun TY; Shinde SN; Paquette WD; Brummond KM; Wipf P; Lazo JS
    Assay Drug Dev Technol; 2009 Jun; 7(3):250-65. PubMed ID: 19530895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of potent and selective Cdc25 phosphatase inhibitors via rapid assembly and in situ screening of Quinonoid-focused libraries.
    Tao Y; Hao X; Jing L; Sun L; Cherukupalli S; Liu S; Wu G; Xu S; Zhang X; Shi X; Song Y; Liu X; Zhan P
    Bioorg Chem; 2021 Oct; 115():105254. PubMed ID: 34426152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel naphthoquinone and quinolinedione inhibitors of CDC25 phosphatase activity with antiproliferative properties.
    Braud E; Goddard ML; Kolb S; Brun MP; Mondésert O; Quaranta M; Gresh N; Ducommun B; Garbay C
    Bioorg Med Chem; 2008 Oct; 16(19):9040-9. PubMed ID: 18789703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrazole-based cathepsin S inhibitors with improved cellular potency.
    Wei J; Pio BA; Cai H; Meduna SP; Sun S; Gu Y; Jiang W; Thurmond RL; Karlsson L; Edwards JP
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5525-8. PubMed ID: 17822900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of highly potent and selective Cdc25 protein phosphatases inhibitors from miniaturization click-chemistry-based combinatorial libraries.
    Jing L; Wu G; Hao X; Olotu FA; Kang D; Chen CH; Lee KH; Soliman MES; Liu X; Song Y; Zhan P
    Eur J Med Chem; 2019 Dec; 183():111696. PubMed ID: 31541869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective Pharmacophore for CDC25 Phosphatases Enzyme Inhibitors: Newly Synthesized Bromothiazolopyrimidine Derivatives.
    El-Shahat M; Salama MAM; El-Farargy AF; Ali MM; Ahmed DM
    Mini Rev Med Chem; 2021; 21(1):118-131. PubMed ID: 32560601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors.
    Park H; Li M; Choi J; Cho H; Ham SW
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4372-5. PubMed ID: 19500977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 1-substituted 3-aryl-5-aryl(hetaryl)-2-pyrazolines and study of their antitumor activity.
    Insuasty B; Chamizo L; Muñoz J; Tigreros A; Quiroga J; Abonía R; Nogueras M; Cobo J
    Arch Pharm (Weinheim); 2012 Apr; 345(4):275-86. PubMed ID: 22105771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of pyrazole derivatives as cellular active inhibitors of histone lysine specific demethylase 5B (KDM5B/JARID1B).
    Zhao B; Liang Q; Ren H; Zhang X; Wu Y; Zhang K; Ma LY; Zheng YC; Liu HM
    Eur J Med Chem; 2020 Apr; 192():112161. PubMed ID: 32155529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of pyrazole carboxylic acids as potent inhibitors of rat long chain L-2-hydroxy acid oxidase.
    Barawkar DA; Bandyopadhyay A; Deshpande A; Koul S; Kandalkar S; Patil P; Khose G; Vyas S; Mone M; Bhosale S; Singh U; De S; Meru A; Gundu J; Chugh A; Palle VP; Mookhtiar KA; Vacca JP; Chakravarty PK; Nargund RP; Wright SD; Roy S; Graziano MP; Cully D; Cai TQ; Singh SB
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4341-7. PubMed ID: 22658862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of novel bis-thiazolone derivatives as micromolar CDC25 phosphatase inhibitors: effect of dimerisation on phosphatase inhibition.
    Sarkis M; Tran DN; Kolb S; Miteva MA; Villoutreix BO; Garbay C; Braud E
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7345-50. PubMed ID: 23141909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological evaluation of novel naphthoquinone derivatives with CDC25 phosphatase inhibitory activity.
    Brun MP; Braud E; Angotti D; Mondésert O; Quaranta M; Montes M; Miteva M; Gresh N; Ducommun B; Garbay C
    Bioorg Med Chem; 2005 Aug; 13(16):4871-9. PubMed ID: 15921913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Synthetic and Biological Attributes of Pyrazole Derivatives: A Review.
    Dwivedi J; Sharma S; Jain S; Singh A
    Mini Rev Med Chem; 2018; 18(11):918-947. PubMed ID: 28971774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of caulibugulones A-E.
    Wipf P; Joo B; Nguyen T; Lazo JS
    Org Biomol Chem; 2004 Aug; 2(15):2173-4. PubMed ID: 15280951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.